New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
09:13 EDTMRGE, CI, SPLS, AEO, WLP, UNH, OMX, PERY, BBY, AET, HUM, ODP, ESRXOn The Fly: Pre-market Movers
HIGHER: Office Depot (ODP), up 28.8%, OfficeMax (OMX), up 22.3%, after WSJ says companies in advanced talks to merge. Rival Staples (SPLS) also up 14.8% after report... Merge Healthcare (MRGE), up 8.1% after quarterly report, concluding evaluation of strategic alternatives... Best Buy (BBY), up 4.8% after upgrades at Stifel Nicolaus, Barclays... American Eagle (AEO), up 3.4% following postive Barron's mention... LOWER: Humana (HUM), down 9.1% Unitedhealth (UNH), down 4.9%, Cigna (CI), down 4.7%, Aetna (AET), down 3%, Wellpoint (WLP), down 2.7%, after Centers for Medicare and Medicaid Services proposes policies to lower Medicare drug costs... UP AFTER EARNINGS: Express Scripts (ESRX), up 4.1%... DOWN AFTER EARNINGS: Perry Ellis (PERY), down 7.5%.
News For ODP;OMX;SPLS;HUM;UNH;CI;AET;WLP;MRGE;BBY;AEO;ESRX;PERY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
May 13, 2015
10:01 EDTHUMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:01 EDTAEOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTPERYPerry Ellis announces men's sportswear license agreement for Farah Vintage brand
Subscribe for More Information
06:35 EDTBBYBest Buy May volatility elevated into Q1 and outlook
Best Buy May weekly call option implied volatility is at 54, June is at 34, September is at 33; compared to its 90-day average of 32 according to Track Data, suggesting large near term price movement into the expected release of Q1 earnings on May 21.
06:12 EDTHUM, CIHumana downgraded to Underperform from Neutral at Sterne Agee CRT
Sterne Agee CRT analyst Brian Wright downgraded Humana (HUM) to Underperform saying speculation about a takeover is "wishful thinking" at current share levels. The stock rallied 4% yesterday after Leerink told investors that Aetna (AET) may acquire Humana or Cigna (CI) in the near-term. Wright also sees "material" risk to Humana's earnings guidance risk with paid claims outpacing premium growth. He lowered his price target for shares to $150 from $165. Humana shares closed yesterday up $6.76 to $173.38.
06:08 EDTAEOAmerican Eagle upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
05:25 EDTSPLSStaples announces partnerships with Bidvest Waltons, Dacris
Subscribe for More Information
May 12, 2015
15:46 EDTHUMHumana May volatility increases on sharp rally
Subscribe for More Information
15:39 EDTCICigna May volatility elevated
Cigna May call option implied volatility is at 35, June is at 28, and August is at 30; compared to its 90-day average of 31, suggesting large near term price movement.
13:03 EDTAETAetna repeats view of FY15 operating EPS $7.20-$7.40, consensus $7.38
Subscribe for More Information
11:53 EDTHUM, CI, AETAnalyst predicts large transaction 'imminent' for Aetna
Subscribe for More Information
10:28 EDTHUMOptions with increasing implied volatility: YELP HUM LULU CTRX
Subscribe for More Information
10:04 EDTAET, HUMHigh option volume stocks
Subscribe for More Information
09:53 EDTHUM, AETAetna merger with Cigna or Humana likely 'imminent,' says Leerink
Subscribe for More Information
May 11, 2015
15:06 EDTAETAetna backs FY15 operating EPS $7.20-$7.40, consensus $7.38
In a regulatory filing earlier, Aetna reported that during upcoming investor meetings in May, the company expects to reaffirm its FY15 operating EPS guidance of $7.20-$7.40. Current FY15 EPS consensus is $7.38.
09:08 EDTPERYPerry Ellis announces bedding license for Laundry by Shelli Segal
Subscribe for More Information
07:40 EDTESRX, UNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information
06:51 EDTAETAetna management to meet with Leerink
Meeting to be held in Hartford, CT on May 11 hosted by Leerink.
06:10 EDTAEOStocks with implied volatility above IV index mean; AEO CBI
Stocks with implied volatility above IV index mean; American Eagle (AEO) 42, Chicago Bridge & Iron (CBI) 55 according to iVolatility.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use